MedTrace Logo

Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis

NCT02580669 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-05-18

No results posted yet for this study

Summary

The goal of this study is to show pattern differences of vasoreactivity and connectivity between Progressive Multiple Sclerosis and Relapsing Remitting Multiple Sclerosis, by the use of methods of advanced brain MRIs and the Diffusion Tensor Imaging , and correlate these differences with Clinical disability and cognitive disorder results.

Conditions

Interventions

OTHER

Neuropsychological assessment

A neuropsychological assessment is done

OTHER

Neurologic consultation

A neurologic consultation is done

OTHER

MRIs (with vasoreactivity testing)

MRIs (with vasoreactivity testing) is done

Sponsors & Collaborators

  • Genzyme, a Sanofi Company

    collaborator INDUSTRY

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Pierre LABAUGE, Professor · University Hospital, Montpellier

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-16
Primary Completion
2017-02-13
Completion
2017-02-13

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02580669 on ClinicalTrials.gov